跳至主要内容
临床试验/NCT01537614
NCT01537614已完成1 期

Pharmacokinetic Study of Aerosolized Colimycin in Cystic Fibrosis

Poitiers University Hospital1 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2011年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
7
试验地点
1

研究概览

简要总结

Pharmacokinetics of colimycin will be assessed during 12 hours after administration of 2M UI colimycin either as an aerosol or after IV injection, the administration being separated by 5 to 10 days intervals

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females, adults.
  • Suffering from stable cystic fibrosis
  • Colonized by P. aeruginosa
  • Having given informed consent.
  • Able to follow the protocol
  • Having a social insurance

排除标准

  • Renal insufficiency
  • Allergy to colistin or polymixins
  • Myasthenia
  • Recent severe hemoptysis
  • Liver cirrhosis and hepatic insufficiency
  • Hypoalbuminemia
  • Colonization by Burkholderia cepaea or Stenotrophomonas maltophilin
  • Pregnancy

研究组 & 干预措施

COLIMYCINE injectable

Experimental

干预措施: COLIMYCINE injectable (Drug)

COLIMYCINE inhalation

Experimental

干预措施: COLIMYCINE inhalation (Drug)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Pharmacokinetic Study of Aerosolized Colimycin in... | 临床试验